FDA Approved: NYVEPRIA — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved NYVEPRIA (pegfilgrastim-APGF) from Pfizer in an original biologics application, establishing a pegfilgrastim biosimilar therapy to support neutroph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Neutropenia

Drugs mentioned

• Nyvepria (pegfilgrastim)

Snippet

ORIG AP for NYVEPRIA (PEGFILGRASTIM-APGF)